The Westermarck Laboratory at Turku Bioscience Centre is accepting applications for a doctoral researcher (PhD) position.

The project investigates the role of NOCIVA, a splicing variant of the oncoprotein CIP2A, in triple negative breast cancer (TNBC), with a focus on its regulation, functional significance, and potential as a biomarker and therapy target.

Candidates should have:

• An MSc degree in biosciences or a related field
• Experience in experimental cancer research
• Good communication and teamwork skills

The position is funded until April 2030, with a starting salary of ~2500–2600 €/month and full Finnish university employment benefits.

Read more and apply HERE